For years, criticism of drug marketing has focused most on reps delivering dubious info and expensive DTC campaigns. But a tide seems to be turning against CME, which is mostly underwritten by drug companies. Daniel Carlat, who is already known for his Carlat Report publication, has started a blog dedicated to banning drug company funded CME. You can check it out here.
« DrugWonks and Michael Moore: Who's 'Demagoging' Who? | Main | Should Brand Names for Drugs Be Banned? »
June 19, 2007
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d834519bc269e200e00982a4a88833
Listed below are links to weblogs that reference Daniel Carlat Starts a Blog to Ban Commercial CME:
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Author
Peter Rost, M.D. writes for BrandweekNRX since August 1, 2007. Dr. Rost is a former VP of Pfizer engaged as a pharma expert witness and pharmaceutical marketing consultant by several law firms. He also writes the daily Pharma Law Blog and is the author of Killer Drug and The Whistleblower. Contact Dr. Rost by clicking here.
Search
February 2008
Categories
Recent Posts
- Hello. Goodbye.
- Pfizer's disgraced Dr. Jarvik talks to Playboy about manufacturing a dildo and his sex life.
- Sex, drugs, doctors, and . . . pharma sales reps.
- Dr. Jarvik: I can row! I can row!
- Pfizer dumps Jarvik after numerous lies exposed.
- EdrugSearch.com Community
- 44% of all cigarettes smoked by people with mental illness.
- Picture of a future president?
- Restrooms and advertising. We love both.
- Nader will run again - and proposes real universal healthcare.
Comments